ACTC opened at 17 cent went down to .1410 and closed at .1530 on 34.2 million shares. Should have bought more at 14+ cent.
Sue Freeman a patient who was injected in the eye with stem cells part of ACTC Phase 1/2 trial, is now share holder. That's the story on Yahoo's Message Broad.
Geron closed at $1.71 on only 616,569 shares. Rumor on Yahoo's Message Broad, Form 4 filed for Scarlett---Scarlett the CEO of Geron purchase of 75,000 shares at $1.72 two days ago.
Good luck in this rigged casino,
No comments:
Post a Comment